CC
Cadinha & Co’s Bristol-Myers Squibb BMY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,333
| Closed | -$203K | – | 102 |
|
2025
Q1 | $203K | Buy |
+3,333
| New | +$203K | 0.04% | 98 |
|
2023
Q1 | – | Sell |
-2,834
| Closed | -$204K | – | 93 |
|
2022
Q4 | $204K | Sell |
2,834
-883
| -24% | -$63.5K | 0.05% | 98 |
|
2022
Q3 | $264K | Sell |
3,717
-192,963
| -98% | -$13.7M | 0.09% | 79 |
|
2022
Q2 | $15.1M | Buy |
+196,680
| New | +$15.1M | 3.38% | 11 |
|
2018
Q4 | – | Sell |
-19,353
| Closed | -$1.2M | – | 108 |
|
2018
Q3 | $1.2M | Sell |
19,353
-193,623
| -91% | -$12M | 0.19% | 62 |
|
2018
Q2 | $11.8M | Sell |
212,976
-947
| -0.4% | -$52.4K | 2.16% | 22 |
|
2018
Q1 | $13.5M | Buy |
213,923
+314
| +0.1% | +$19.9K | 2.73% | 17 |
|
2017
Q4 | $13.1M | Buy |
213,609
+36,309
| +20% | +$2.23M | 1.81% | 25 |
|
2017
Q3 | $11.3M | Buy |
177,300
+161,540
| +1,025% | +$10.3M | 1.93% | 23 |
|
2017
Q2 | $878K | Buy |
15,760
+11,395
| +261% | +$635K | 0.15% | 64 |
|
2017
Q1 | $237K | Sell |
4,365
-4,718
| -52% | -$256K | 0.05% | 113 |
|
2016
Q4 | $531K | Buy |
9,083
+3,975
| +78% | +$232K | 0.09% | 73 |
|
2016
Q3 | $275K | Hold |
5,108
| – | – | 0.06% | 102 |
|
2016
Q2 | $376K | Buy |
5,108
+100
| +2% | +$7.36K | 0.08% | 86 |
|
2016
Q1 | $320K | Buy |
5,008
+325
| +7% | +$20.8K | 0.08% | 87 |
|
2015
Q4 | $322K | Buy |
4,683
+37
| +0.8% | +$2.54K | 0.08% | 81 |
|
2015
Q3 | $275K | Hold |
4,646
| – | – | 0.07% | 86 |
|
2015
Q2 | $309K | Hold |
4,646
| – | – | 0.06% | 87 |
|
2015
Q1 | $300K | Hold |
4,646
| – | – | 0.06% | 91 |
|
2014
Q4 | $274K | Hold |
4,646
| – | – | 0.05% | 97 |
|
2014
Q3 | $238K | Hold |
4,646
| – | – | 0.04% | 97 |
|
2014
Q2 | $225K | Hold |
4,646
| – | – | 0.04% | 100 |
|
2014
Q1 | $241K | Sell |
4,646
-4,500
| -49% | -$233K | 0.04% | 93 |
|
2013
Q4 | $486K | Hold |
9,146
| – | – | 0.09% | 71 |
|
2013
Q3 | $423K | Hold |
9,146
| – | – | 0.08% | 68 |
|
2013
Q2 | $409K | Buy |
+9,146
| New | +$409K | 0.09% | 61 |
|